Vitestro logo — We transform patient care with autonomous blood drawing tech...

Vitestro

We transform patient care with autonomous blood drawing technology

Founded 2017 The Netherlands The Netherlands 132 employees Series B Total: $102.00M Health Care, Medical Devices

General Information

Company Name Vitestro
Founded Year 2017
Location The Netherlands The Netherlands +1
Employees 132
Industries Health Care, Medical Devices
Funding Stage Series B
Social

Get notified when Vitestro moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Recorded by Bounce Watch from public sources. Every entry below carries the date we observed it, and when we have not looked recently the page says so rather than leaving silence to imply nothing happened.

In The News Sep 03, 2026

Featured on Tech: The Netherlands' top-funded tech companies in H1 2026

Recently Funded Aug 25, 2026

Raised $70M in Series B round.

In The News Aug 25, 2026

Featured on Thenextweb: A robot that takes blood could be the best AI health story of 2026

AI Insight

Bounce Watch AI
1 month ago

Vitestro's recent hiring for 5 positions indicates ongoing team expansion, likely bolstering capabilities for future product development or market entry. Concurrently, a significant website update (73.82% change) suggests a strategic refresh of their public messaging, potentially preceding new feature announcements or an imminent formal commercialization push for their autonomous blood drawing technology, post-Series A funding.

Signal Types
Hiring Product Update
Strategic Labels
Team Expansion Market Strategy Update
Next Move: Product Launch
·
Impact: 7/10
·
Ideal For: MedTech VCs – Growth Stage

About Vitestro

Vitestro, founded in 2017, is pioneering the way in healthcare technology with its breakthrough in autonomous blood drawing solutions. With the compelling slogan, "We transform patient care with autonomous blood drawing technology", the company stands at the forefront of the Health Care and Medical Devices industries.

The Netherlands-based startup addresses critical gaps in healthcare, with traditional blood drawing being a pivotal diagnostic tool that's performed billions of times annually. As the demand for diagnostics surges due to population growth and workforce shortages, Vitestro offers a much-needed future-proof solution for European hospitals.

The company recently secured a €20.00M Series A investment on 30 April 2024, demonstrating strong confidence from investors. This round was led by the European Innovation Council, Invest-NL, Sonder Capital, and NYBC Ventures, underscoring a significant vote of confidence in Vitestro's innovative approach to medical advancements.

Taxonomy: autonomous blood drawing, clinical diagnostics, robotics, phlebotomy, venipuncture, precision robotics, patient care innovation, healthcare automation, diagnostic innovation, healthcare efficiency, pre-analytical processes

Services & Products

Autonomous Robotic Phlebotomy Device (ARPD)
Clinical trials for safety and efficacy
Hospital and laboratory collaborations
Engineering and technology for healthcare

Target Customers

laboratory specialists hospital leadership phlebotomists patients healthcare institutions

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B •••••• 4
Investor
•••• ••••
25 Aug 2026
Grant •••••• 1
Investor
30 Apr 2024
Series A •••••• 4
Investor Investor Investor Investor
30 Apr 2024
Non Equity Assistance •••••• 1
Investor
06 Jun 2023
Series A •••••• 2
Investor Investor
21 Mar 2023

Vitestro Alternatives & Competitors

View All Alternatives
Vitestro vs

Specializing in comprehensive care for arthritis and immunological diseases with state-of-the-art di...

2 employees
Health Care
Vitestro vs

Lifesaving is what we are all about. Live local. Give local.

133 employees
Health Care
Vitestro vs
Truvian
Truvian United States

blood testing anyone. anywhere.

Series Unknown
108 employees
Biotechnology, Health Care

FAQ About Vitestro

We transform patient care with autonomous blood drawing technology
Vitestro was founded in 2017.
Vitestro is headquartered in The Netherlands.
Vitestro operates in the following industries: Health Care, Medical Devices.
Vitestro has approximately 132 employees.
Vitestro has completed 5 funding rounds, raising a total of $102.00M. The latest funding stage is Series B.
Vitestro offers: Autonomous Robotic Phlebotomy Device (ARPD), Clinical trials for safety and efficacy, Hospital and laboratory collaborations, Engineering and technology for healthcare.
Top alternatives and competitors to Vitestro include ARTHRITIS & OSTEOPOROSIS CENTER, INC, Kentucky Blood Center, Truvian, Simply Blood, Capitainer. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Vitestro and ARTHRITIS & OSTEOPOROSIS CENTER, INC are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Vitestro and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy